Sentinus LLC’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,925
| Closed | -$3.55K | – | 210 |
|
|
2024
Q4 | $3.55K | Buy |
+12,925
| New | +$3.55K | ﹤0.01% | 182 |
|
|
2024
Q3 | – | Sell |
-12,925
| Closed | -$5.52K | – | 197 |
|
|
2024
Q2 | $5.52K | Buy |
+12,925
| New | +$5.52K | ﹤0.01% | 182 |
|
|
2023
Q2 | $1.4M | Buy |
2,469,440
+279,000
| +13% | +$158K | 0.44% | 42 |
|
|
2023
Q1 | $1.37M | Buy |
2,190,440
+395,650
| +22% | +$247K | 0.46% | 46 |
|
|
2022
Q4 | $1.45M | Buy |
1,794,790
+600,375
| +50% | +$484K | 0.85% | 30 |
|
|
2022
Q3 | $1.02M | Buy |
+1,194,415
| New | +$1.02M | 0.64% | 36 |
|